Synartro Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.08M
- Investors
-
3
Synartro General Information
Description
Developer of local injection treatments designed to provide sustained efficacy for osteoarthritis. The company develops local injection treatments that provide superior and sustained efficacy without systemic side effects, which leads to improved treatments using patented delivery technology that offers a sustained drug release combined with existing proven drugs, enabling clinicians to slow down and stop the disease progression entirely.
Contact Information
Website
www.synartro.comCorporate Office
- Vasagatan 28
- 111 20 Stockholm
- Sweden
Corporate Office
- Vasagatan 28
- 111 20 Stockholm
- Sweden
Synartro Timeline
Synartro Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 09-Oct-2025 | $2.08M | Completed | Pre-Clinical Trials | ||
| 4. Later Stage VC | 01-May-2023 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 25-Oct-2021 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 04-Nov-2020 | $1.92M | $7.92M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 05-May-2020 | $6M | $6M | Completed | Pre-Clinical Trials |
Synartro Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Synartro Comparisons
Industry
Financing
Details
Synartro Competitors (6)
One of Synartro’s 6 competitors is Novartis, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland | ||||
| Ferring | Private Equity-Backed | Saint-Prex, Switzerland | ||||
| Sanofi | Corporation | Gentilly, France | ||||
| GSK | Corporation | London, United Kingdom | ||||
| Anika Therapeutics | Formerly VC-backed | Bedford, MA |
Synartro Patents
Synartro Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202216467-D0 | Pharmaceutical formulation | Inactive | 04-Nov-2022 | ||
| JP-2026528114-A | Liquid formulation | Pending | 16-Aug-2022 | ||
| EP-4777151-A1 | Liquid formulations | Pending | 16-Aug-2022 | ||
| WO-2024038088-A1 | Liquid formulations | Inactive | 16-Aug-2022 | ||
| JP-2026526254-A | Method for preparing a sterilization composition | Pending | 16-Aug-2022 | A61K47/61 |
Synartro Signals
Synartro Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Phase2Phase Biopharma | Venture Capital | Minority | ||
| Sciety | Venture Capital | Minority | ||
| Linc (Sweden) | Venture Capital | Minority |
Synartro FAQs
-
When was Synartro founded?
Synartro was founded in 2011.
-
Where is Synartro headquartered?
Synartro is headquartered in Stockholm, Sweden.
-
What is the size of Synartro?
Synartro has 6 total employees.
-
What industry is Synartro in?
Synartro’s primary industry is Drug Discovery.
-
Is Synartro a private or public company?
Synartro is a Private company.
-
What is Synartro’s current revenue?
The current revenue for Synartro is .
-
How much funding has Synartro raised over time?
Synartro has raised $14.7M.
-
Who are Synartro’s investors?
Phase2Phase Biopharma, Sciety, and Linc (Sweden) have invested in Synartro.
-
Who are Synartro’s competitors?
Novartis, Ferring, Sanofi, GSK, and Anika Therapeutics are some of the 6 competitors of Synartro.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process